Engineered Bispecific Antibodies (BsAb) Novel Approaches & Pipeline Insights, 2016; New Report Launched
Engineered Bispecific Antibodies (BsAb) Novel Approaches & Pipeline Insights, 2016" emphasizes on the novel bispecific antibodies technologies in research and development. The report enlists company, target antigens, phase and indication specific R&D pipelines of Bispecifc Antibodies (bsAbs). It includes information about 18 companies with 41 products in pipeline based on 19 different technologies. The report also covers other commercial aspects such as the market assessment of the pipeline drugs, future drugs approval timeline, current and future pipeline scenario. The report...
View full press release